Acquisition Of Zevacor Pharma Complete, Rebranding As SOFIE

28 September 2017

Sofie Biosciences, Inc., the molecular imaging company specializing in novel tools for PET imaging and radiosynthesis of PET compounds, has today announced the completion of the acquisition of Zeva